Disclosure notice

Som en följd av den nyligen genomförda företrädesemissionen i  CombiGene AB har Lars Thunbergs ägarandel i CombiGene minskat till under 20 procent.
Läs mer >>

Share

News

January 9, 2025

Stockslätten AB acquires all shares from Strategic Partners A/S

January 9, 2025

Clarification regarding the management’s role during the restructuring period

January 9, 2025

CombiGene initiates restructuring as part of strategic review to maximize shareholder value

December 17, 2024

CombiGene AB (publ): Nominating committee

December 10, 2024

Bulletin from the Extraordinary General Meeting of CombiGene AB (publ)

December 2, 2024

CombiGene conducts Extraordinary General Meeting

November 14, 2024

Shareholders’ proposal for election of Board of Directors

November 8, 2024

Interim report January – September 2024 for CombiGene AB (publ)

Load more